SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0001213900-24-001517
Filing Date
2024-01-05
Accepted
2024-01-05 16:08:25
Documents
4

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea191118-8k425_phoenix.htm 425 39692
2 THIRD AMENDMENT TO THE AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF PHOE ea191118ex3-1_phoenix.htm EX-3.1 14582
3 CERTIFICATE OF CORRECTION TO THE THIRD AMENDMENT TO THE AMENDED AND RESTATED CER ea191118ex3-2_phoenix.htm EX-3.2 19840
4 AMENDMENT NO. 3 TO THE INVESTMENT MANAGEMENT TRUST AGREEMENT, DATED JANUARY 3, 2 ea191118ex10-1_phoenix.htm EX-10.1 19989
  Complete submission text file 0001213900-24-001517.txt   95847
Mailing Address 2001 MARKET STREET SUITE 3400 PHILADELPHIA PA 19103
Business Address 2001 MARKET STREET SUITE 3400 PHILADELPHIA PA 19103 2157319450
PHOENIX BIOTECH ACQUISITION CORP. (Filed by) CIK: 0001870404 (see all company filings)

IRS No.: 871088814 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 2001 MARKET STREET SUITE 3400 PHILADELPHIA PA 19103
Business Address 2001 MARKET STREET SUITE 3400 PHILADELPHIA PA 19103 2157319450
PHOENIX BIOTECH ACQUISITION CORP. (Subject) CIK: 0001870404 (see all company filings)

IRS No.: 871088814 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425 | Act: 34 | File No.: 001-40877 | Film No.: 24516309
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)